Immuron progresses development of traveller's diarrhea drug Travelan
Immuron Ltd has presented a Clinical Study Report to the US Food and Drug Administration following its Phase 2 clinical trial
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
La Trobe Financial Capital Markets Trust 2024-2
| Forum | Tag | Subject | View | Poster | |||||
|---|---|---|---|---|---|---|---|---|---|
| ASX - By Stock | LR5 | Ann: Deed of Amendment and Accession | Thread |
 ASX News
|
0 | 149 | 0 | 19/12/24 | |
|
|||||||||
| ASX - By Stock | LR5 | Ann: Series Supplement | Thread |
ASX News
|
0 | 133 | 0 | 19/12/24 | |
|
|||||||||
| ASX - By Stock | LR5 | Ann: General Security Deed | Thread |
ASX News
|
0 | 194 | 0 | 19/12/24 | |
|
|||||||||
| ASX - By Stock | LR5 | Ann: Information Memorandum | Thread |
ASX News
|
0 | 278 | 0 | 19/12/24 | |
|
|||||||||
| ASX - By Stock | LR5 | Ann: Appendix 1B, Information Form and Checklist | Thread |
ASX News
|
0 | 138 | 0 | 19/12/24 | |
|
|||||||||
| ASX - By Stock | LR5 | Ann: Admission and Commencement as an ASX Debt Listing | Thread |
ASX News
|
0 | 138 | 0 | 19/12/24 | |
|
|||||||||
 (20min delay)
|
|||||
|
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $0 | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
